Results 101 to 110 of about 655,916 (248)
Portability of Scientific Manuscripts and Reviewers’ Comments
Journal of Clinical Interventional Radiology ISVIR, 2022 Shoban Haridass +2 more
doaj +1 more source
Reviewing scientific manuscripts in 2023: is it (still) worth the time? [PDF]
EuroIntervention, 2023 Amabile N, Stefanini G.
europepmc +1 more source
The final report for progress during the period from 15 Nov. 1988 to 14 Nov. 1991 is presented. Research on methods for analysis of sound propagation through the atmosphere and on results obtained from application of our methods are summarized.
Jacobson, M. J. +2 more
core +1 more source
Molecular Oncology, EarlyView.Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon +13 more
wiley +1 more source
Hebrew Medical Manuscripts in Portugal between the 13th and the 16th centuries [PDF]
Revista da Faculdade de Letras. Série de História, 2016 Portugal has been an important Jewish intellectual center in the Middle Ages and during the 16th century. The Hebrew manuscripts that survive from this period testify to the prosperity of the Jewish community in different fields such as philosophy ...
Irina Visan
doaj
Authorship in Scientific Manuscripts. [PDF]
Indian J Orthop, 2023 Kambhampati SBS, Maini L.
europepmc +1 more source
LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro
Molecular Oncology, EarlyView.Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix +13 more
wiley +1 more source
Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
Molecular Oncology, EarlyView.The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla +10 more
wiley +1 more source
Reviewer's Checklists for Evaluating Scientific Manuscripts. [PDF]
Indian J Orthop, 2022 Vishwanathan K +2 more
europepmc +1 more source
Molecular Oncology, EarlyView.Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff +11 more
wiley +1 more source